TY - JOUR
KW - Narcotics -- Adverse Effects
KW - Substance Use Disorders -- Drug Therapy
KW - Methadone -- therapeutic use
KW - Ethnic Groups -- Psychosocial Factors
KW - Drug Utilization
KW - Healthcare Disparities
KW - Racial Equality
KW - Racism -- Prevention and Control
KW - Health Services Accessibility
KW - Stigma -- Prevention and Control
KW - Buprenorphine -- Therapeutic Use
KW - Medicaid expansion
KW - Health Care Reform
KW - Medication Compliance
KW - Grants
KW - Insurance Coverage
AU - Barbara Andraka-Christou
A1 - 
AD - Department of Internal Medicine. She is also a licensed attorney in the state of Florida
BT - Health affairs
C5 - Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
CP - 6
CY - Bethesda, Maryland
DO - 10.1377/hlthaff.2020.02261
IS - 6
JF - Health affairs
LA - English
M1 - Journal Article
PB - Project HOPE/HEALTH AFFAIRS
PP - Bethesda, Maryland
PY - 2021
SN - 0278-2715
SP - 920
EP - 927
EP - 
T1 - Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder
T2 - Health affairs
TI - Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder
U1 - Financing & Sustainability; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1377/hlthaff.2020.02261
VL - 40
VO - 0278-2715
Y1 - 2021
Y2 - 06
ER -